Reversible upper limb muscle weakness with selective loss of thick filaments

Neurology

Volumn 61, Issue 6, 2003, Pages 863-864

  Vattemi, G ^b   Tonin, P ^b   Filosto, M ^b   Savio, C ^b   Rizzuto, N ^b   Tomelleri, Giuliano ^a  

^a Policlinico GB Rossi   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; ELECTROMYOGRAM; ELECTRON MICROSCOPY; HUMAN; IMMUNOBLOTTING; IMMUNOREACTIVITY; MALE; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOFILAMENT; MYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUADRIPLEGIA;

EID: 0141764906     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.61.6.863     Document Type: Article

References (7)

1. Engel AG, Banker BQ. Ultrastructural changes in diseased muscle. In: Engel AG, Franzini-Armstrong C, eds. Myology, 2nd ed. New York: McGraw-Hill, 1994;930-931.
2. Bertini E, Bosman C, Salviati G, et al. Myopathy and hypertrophic cardiomyopathy with selective lysis of thick filaments. Virchows Arch A Pathol Anat Histopathol 1993;422:327-331.
3. Gonzales MF, Olney RK, So YT, et al. Subacute structural myopathy associated with human immunodeficiency virus infection. Arch Neurol 1988;45:585-587.
4. Showalter CJ, Engel AG. Acute quadriplegic myopathy: analysis of myosin isoforms and evidence for calpain-mediated proteolysis. Muscle Nerve 1997;20:316-322.
5. Deconinck N, Van Parijs V, Beckers-Bleukx G, Van den Bergh P. Critical illness myopathy unrelated to corticosteroids or neuromuscular blocking agents. Neuromuscul Disord 1998;8:186-192.
6. Hoke A, Rewcastle NB, Zochodne DW. Acute quadriplegic myopathy unrelated to steroids or paralyzing agents: quantitative EMG studies. Can J Neurol 1999;26:325-329.
7. Squier MK. Calpain activation in apoptosis. J Cell Physiol 1994;159:229-237.